HuGE Literature Finder
Records
1
-
9
| Genomic Profiling Identified Prognostic Biomarkers of Definitive Chemo-Radiotherapy Response in Esophageal Carcinoma. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): S13. Li L, Yuan S, Sun J, Yin Y, Cui J, Zhang J, Chen Y, Pang J, Yin J, Shao Y, Yu |
| Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. Hepatobiliary surgery and nutrition 2021 Apr 10 (2): 172-179. Wang Shuo, Shi Huasheng, Liu Tao, Li Manjiang, Zhou Sanshun, Qiu Xuan, Wang Zusen, Hu Weiyu, Guo Weidong, Chen Xiaoqian, Guo Honglin, Shi Xiaoliang, Shi Junping, Zang Yunjin, Cao Jingyu, Wu Liq |
| Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma. OncoTargets and therapy 2020 13 12797-12809. Zhang Nan, Shi Junping, Shi Xiaoliang, Chen Wenting, Liu Junfe |
| YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma. Cancer medicine 2019 Dec . Dai Honghai, Shao Yang W, Tong Xiaoling, Wu Xue, Pang Jiaohui, Feng Alei, Yang Z |
| Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment. Oncotarget 2016 Aug 7 (31): 49091-49098. Kaibori Masaki, Sakai Kazuko, Ishizaki Morihiko, Matsushima Hideyuki, De Velasco Marco A, Matsui Kosuke, Iida Hiroya, Kitade Hiroaki, Kwon A-Hon, Nagano Hiroaki, Wada Hiroshi, Haji Seiji, Tsukamoto Tadashi, Kanazawa Akishige, Takeda Yutaka, Takemura Shigekazu, Kubo Shoji, Nishio Kazu |
| Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients. Oncotarget 2016 Mar . Li Fan, Xia Weiliang, Wang Guan, Tan Qiang, Li Ziming, Niu Xiaomin, Ji Wenxiang, Yuan Hong, Xu Qiang, Luo Qingquan, Zhang Jie, Lu Sh |
| Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. Oncotarget 2014 May 5 (10): 3012-22. Janku Filip, Kaseb Ahmed O, Tsimberidou Apostolia M, Wolff Robert A, Kurzrock Razel |
| FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. International journal of cancer. Journal international du cancer 2009 Jun 124 (12): 2880-5. Falvella Felicia S, Frullanti Elisa, Galvan Antonella, Spinola Monica, Noci Sara, De Cecco Loris, Nosotti Mario, Santambrogio Luigi, Incarbone Matteo, Alloisio Marco, Calabrò Elisa, Pastorino Ugo, Skaug Vidar, Haugen Aage, Taioli Emanuela, Dragani Tommaso |
| Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. Journal of hepatology 2009 Jan 50 (1): 118-27. Ho Han Kiat, Pok Sharon, Streit Sylvia, Ruhe Jens E, Hart Stefan, Lim Kah Suan, Loo Hooi Linn, Aung Myat Oo, Lim Seng Gee, Ullrich Ax |
- Page last reviewed:Jul 25, 2022
- Page last updated:Nov 22, 2022
- Content source: